DPP4 and chronic myelogenous leukemia, BCR-ABL1 positive: The evidence that in our study about 30% of CML patients on TKI treatment do not show detectable CD26+ LSCs by flow cytometry may be due to the sensitivity of the assay but may also reflect a real exhaustion of LSCs.